Applications for ROCK kinase inhibition
Top Cited Papers
- 20 February 2008
- journal article
- review article
- Published by Elsevier in Current Opinion in Cell Biology
- Vol. 20 (2) , 242-248
- https://doi.org/10.1016/j.ceb.2008.01.002
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Usefulness of Fasudil, a Rho-kinase Inhibitor, to Treat Intractable Severe Coronary Spasm after Coronary Artery Bypass SurgeryJournal of Cardiovascular Pharmacology, 2004
- Rho Kinase Inhibition Initiates Apoptosis in Human Airway Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2004
- ROCK inhibitor (Y27632) increases apoptosis and disrupts the actin cortical mat in embryonic avian corneal epitheliumDevelopmental Dynamics, 2004
- Rho-Kinase Inhibition Reduces Neointima Formation after Vascular Injury by Enhancing Bax Expression and ApoptosisJournal of Cardiovascular Pharmacology, 2003
- Targeted Disruption of the Mouse Rho-Associated Kinase 2 Gene Results in Intrauterine Growth Retardation and Fetal DeathMolecular and Cellular Biology, 2003
- Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstructionKidney International, 2002
- The GTP binding proteins Gem and Rad are negative regulators of the Rho–Rho kinase pathwayThe Journal of cell biology, 2002
- Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic AnginaCirculation, 2002
- Possible Involvement of Rho-Kinase in the Pathogenesis of Hypertension in HumansHypertension, 2001
- Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK INature Cell Biology, 2001